US28658R1068 - Common Stock
ELIEM THERAPEUTICS INC
NASDAQ:ELYM (5/17/2024, 7:00:02 PM)
After market: 8.25 0 (0%)8.25
+0.07 (+0.86%)
Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company is headquartered in Wilmington, Delaware and currently employs 30 full-time employees. The company went IPO on 2021-08-10. The company is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company is developing a pipeline of clinically differentiated product candidates focused on validated mechanisms of action with therapeutic potential to deliver improved therapeutics for patients with these disorders. Its lead program is ETX-123, a Kv7.2/3 potassium channel opener. Kv7.2/3 has been clinically validated as a therapeutic target for both epilepsy and pain, with further encouraging clinical data in depression. Its ETX-123 lead candidate is an generate new chemical entities designed to harness the efficacy of the Kv7.2/3 channel mechanism while attempting to improve the safety and tolerability relative to earlier molecules, based on its insights into the mechanisms of toxicity and the potency and selectivity profile.
ELIEM THERAPEUTICS INC
2801 Centerville Road 1St Floor, Pmb #117
Wilmington DELAWARE
P: 18773543689
CEO: Robert Azelby
Employees: 30
Website: https://eliemtx.com/
Eliem Therapeutics just reported results for the first quarter of 2024.
Which stocks are experiencing notable movement on Friday?
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Which stocks are experiencing notable movement on Tuesday?
/PRNewswire/ -- Kaskela Law LLC, announces that it is investigating Eliem Therapeutics, Inc. (NASDAQ: ELYM) ("Eliem") on behalf of the company's shareholders....
Here you can normally see the latest stock twits on ELYM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: